StockData
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc (SNDX) stock

SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$8.56−0.64 (-6.96%)

Close on Nov 18, 2026Market cap $764.38MP/E –Yield –

Syndax Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Syndax Pharmaceuticals's total debt was $344.10M at Sep 30, 2026. For fiscal 2025 it was $343.91M, down 49.1% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$343.91M-49.1%
FY2024Dec 31, 2024$675.25M–
FY2023Dec 31, 2023$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$344.10M+0.1%
Q2 FY2026Jun 30, 2026$344.03M+0.1%
Q1 FY2026Mar 31, 2026$343.97M+0.1%
Q4 FY2025Dec 31, 2025$343.91M-49.1%
Q3 FY2025Sep 30, 2025$343.91M–
Q2 FY2025Jun 30, 2025$343.85M–
Q1 FY2025Mar 31, 2025$343.79M–
Q4 FY2024Dec 31, 2024$675.25M–
Q4 FY2023Dec 31, 2023$0–

More Syndax Pharmaceuticals figures

See a number that looks wrong?